Relapsed Refractory Rheumatic And Immunologic Disease Associated Haemophagocytic Lymphohistiocytosis

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Relapsed Refractory Rheumatic And Immunologic Disease Associated Haemophagocytic Lymphohistiocytosis trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 3

NCT07208058

A Phase III Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of Plonmarlimab in Subjects With Relapsed/…

A study designed to evaluate the efficacy, safety, immunogenicity, PK, and PD characteristics of Plonmarlimab in patients with relapsed/refractory rheumatic and…

China30 participantsStarted 2025-11-21

Treatment: Plonmarlimab

Relapsed Refractory Rheumatic And Immunologic Disease Associated Haemophagocytic Lymphohistiocytosis

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

A Phase III Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of Plonmarlimab in Subjects With Relapsed/…

All recent trials (1 shown)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

A Phase III Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of Plonmarlimab in Subjects With Relapsed/…

All recent trials (1 shown)